Skip to main content
. 2023 Apr 28;31(Suppl 1):235–246. doi: 10.3233/THC-236020

Table 3.

Empirical data before and after treatment for each group (mean ± standard deviation)

Pre-intervention Post-intervention
Indicator Acupoint stimulation group Muscle stimulation group Control group P value η2 Acupoint stimulation group Muscle stimulation group Control group P value η2
RPE 18.50 ± 0.60 18.55 ± 0.61 18.45 ± 0.67 0.902 0.03 8.75 ± 0.85 8.65 ± 0.81 10.45 ± 1.50 0.001 0.30
HR 185.90 ± 7.02 183.20 ± 5.98 183.20 ± 10.94 0.188 0.02 88.65 ± 4.45 86.15 ± 7.66 93.35 ± 8.78 0.009 0.15
SCL (max) 28.80 ± 10.09 31.06 ± 10.51 27.86 ± 12.77 0.322 0.05 44.91 ± 21.89 38.53 ± 12.47 27.99 ± 12.33 0.003 0.17
SCL (min) 23.98 ± 6.60 26.40 ± 9.47 23.57 ± 9.93 0.394 0.002 31.87 ± 13.53 32.73 ± 9.88 25.09 ± 11.61 0.016 0.11
SCL (v) 4.80 ± 8.11 4.66 ± 4.21 4.29 ± 4.90 0.804 0.03 13.04 ± 20.69 5.80 ± 5.22 2.90 ± 1.97 0.044 0.07
SCL (mean) 25.99 ± 6.92 28.33 ± 9.53 25.28 ± 10.69 0.319 0.005 36.15 ± 14.01 35.20 ± 10.74 26.34 ± 11.85 0.006 0.15
HRV (hf) 13.51 ± 8.53 14.76 ± 7.95 13.69 ± 6.53 0.859 0.005 36.10 ± 18.42 22.59 ± 12.09 27.92 ± 9.33 0.020 0.10
HRV (lf) 8.08 ± 6.00 8.38 ± 5.12 8.33 ± 4.50 0.856 0.03 19.31 ± 10.53 12.88 ± 8.24 16.18 ± 7.88 0.093 0.05
HRV (lf/hf) 0.57 ± 0.15 0.56 ± 0.14 0.61 ± 0.12 0.596 0.02 0.53 ± 0.11 0.56 ± 0.13 0.56 ± 0.15 0.679 0.01
SPO2 (mean) 99.10 ± 1.17 99.59 ± 0.56 99.10 ± 1.80 0.360 0.001 97.96 ± 1.17 98.07 ± 1.56 98.45 ± 1.49 0.493 0.01